Learn about key people, innovations and trends in San Diego’s thriving tech and biotech industries.

Contact us at sales@sddt.com to get more involved.

  • FDA proposes changes in approval process

    San Diego medical device makers have mixed reviews for proposed changes to the way the U.S. Food and Drug Administration approves their products.

  • Cushman & Wakefield has San Diego’s only real estate team dedicated solely to life sciences industry

    Cushman & Wakefield Global Life Sciences Practice Group is San Diego County’s most experienced real estate team specializing exclusively in meeting the unique facility needs of the area’s life science, pharmaceutical and clean tech companies. The group regularly negotiates more than 65 percent of all local life sciences transactions, totaling more than $1 billion and 5 million square feet of space -- making it San Diego’s leading laboratory tenant rep team for the life sciences industry.

  • Rudolph and Sletten has a long tradition of efficient building in San Diego

    Over the course of 50 years, Rudolph and Sletten has had the opportunity to iron out the kinks, so to speak, of its operational strategies. As a result, the company is a well-oiled machine with a unique and efficient way of approaching business internally and externally. According to the company’s CEO, Martin Sisemore, the construction process for Rudolph and Sletten follows a simple formula: ownership, relationship and transparency equal predictability.

  • Drug may slow growth of early prostate cancer

    A new study suggests a way to help men with early, low-risk prostate cancer avoid being overtreated for a disease that in most cases will never threaten their lives. It found that a drug can slow the growth of these tumors in men who opt to be monitored instead of having treatment right away.

  • Controversial report causes stir in local scientific, clean tech community

    In late January, the nonprofit global policy think tank the RAND Corporation caused a stir in the alternative fuels industry, particularly among makers of algae fuel.

  • SDSU institute helps bring defense technologies to market

    Rick Puetter founded Pixon Imaging with the goal of making bad pictures look good, by developing a circuit board that can be embedded in cameras, binoculars, medical imaging equipment and even unmanned aerial vehicles, or UAVs.

  • SDSU researchers paving way for better vaccines

    Researchers in San Diego State University’s BioScience Center have developed a new platform for vaccines that could improve their effectiveness.

Roundtables

Profiles

National News

  • Drug may slow growth of early prostate cancer

    A new study suggests a way to help men with early, low-risk prostate cancer avoid being overtreated for a disease that in most cases will never threaten their lives. It found that a drug can slow the growth of these tumors in men who opt to be monitored instead of having treatment right away.

Archived Reports

Who's Who in Tech & Biotech - 2010

Find out Who's Who in Tech & Biotech as we profile a few executives turning local companies into regional success stories.

Who's Who in Tech & Biotech - 2009

Meet some of the executives behind some of San Diego's thriving technology and biotech companies, along with news about IP issues, the latest products and innovations.

Who's Who in Tech & Biotech - 2008

Take a closer look at some of the leading CEOs turning local tech and biotech companies into regional success stories.

Who's Who in Tech & Biotech - 2006

Find out how high-tech and biotech companies continue to impact our economy in this annual report. We profile some of the local CEOs and feature a roundtable discussion hosted by Connect.